

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.44811529 |
| 2 | sarcomere organization (GO:0045214) | 8.66262668 |
| 3 | myofibril assembly (GO:0030239) | 7.87553589 |
| 4 | regulation of cardioblast differentiation (GO:0051890) | 7.86004104 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.63029710 |
| 6 | cardiac muscle cell development (GO:0055013) | 6.99854993 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.93576759 |
| 8 | muscle filament sliding (GO:0030049) | 6.91427618 |
| 9 | actin-myosin filament sliding (GO:0033275) | 6.91427618 |
| 10 | cardiac muscle hypertrophy (GO:0003300) | 6.82816483 |
| 11 | cardiac muscle contraction (GO:0060048) | 6.78452827 |
| 12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.72167821 |
| 13 | cardiac cell development (GO:0055006) | 6.57331905 |
| 14 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 6.49246995 |
| 15 | adult heart development (GO:0007512) | 6.42900150 |
| 16 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.42259754 |
| 17 | regulation of sarcomere organization (GO:0060297) | 6.42094876 |
| 18 | striated muscle hypertrophy (GO:0014897) | 6.41714642 |
| 19 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.40188434 |
| 20 | actin-mediated cell contraction (GO:0070252) | 5.98395349 |
| 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.97478934 |
| 22 | regulation of actin filament-based movement (GO:1903115) | 5.87703120 |
| 23 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.85963256 |
| 24 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.85859146 |
| 25 | actomyosin structure organization (GO:0031032) | 5.83699803 |
| 26 | muscle hypertrophy (GO:0014896) | 5.74471007 |
| 27 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.71331672 |
| 28 | regulation of relaxation of muscle (GO:1901077) | 5.68561026 |
| 29 | * muscle tissue morphogenesis (GO:0060415) | 5.65681866 |
| 30 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.61242319 |
| 31 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 5.54948909 |
| 32 | heart trabecula formation (GO:0060347) | 5.51503629 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.49817586 |
| 34 | negative regulation of myotube differentiation (GO:0010832) | 5.37037952 |
| 35 | ventricular cardiac muscle cell development (GO:0055015) | 5.32584325 |
| 36 | regulation of the force of heart contraction (GO:0002026) | 5.23530028 |
| 37 | atrioventricular valve morphogenesis (GO:0003181) | 5.21075014 |
| 38 | heart contraction (GO:0060047) | 5.16149638 |
| 39 | heart process (GO:0003015) | 5.16149638 |
| 40 | cardiac muscle adaptation (GO:0014887) | 5.07711881 |
| 41 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 5.07711881 |
| 42 | muscle hypertrophy in response to stress (GO:0003299) | 5.07711881 |
| 43 | tricarboxylic acid cycle (GO:0006099) | 4.97431181 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 4.90860968 |
| 45 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.87006617 |
| 46 | striated muscle contraction (GO:0006941) | 4.84708765 |
| 47 | cell communication involved in cardiac conduction (GO:0086065) | 4.79906720 |
| 48 | cell communication by electrical coupling (GO:0010644) | 4.79530313 |
| 49 | * atrial septum morphogenesis (GO:0060413) | 4.79310695 |
| 50 | regulation of striated muscle cell apoptotic process (GO:0010662) | 4.63631223 |
| 51 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.59148614 |
| 52 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.54262512 |
| 53 | actin filament-based movement (GO:0030048) | 4.51141153 |
| 54 | cardiac ventricle formation (GO:0003211) | 4.43945003 |
| 55 | * cardiac chamber formation (GO:0003207) | 4.43945003 |
| 56 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 4.42317269 |
| 57 | regulation of cardiac muscle contraction (GO:0055117) | 4.40029951 |
| 58 | regulation of membrane repolarization (GO:0060306) | 4.37573928 |
| 59 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 4.30256027 |
| 60 | embryonic heart tube development (GO:0035050) | 4.28870653 |
| 61 | carnitine shuttle (GO:0006853) | 4.26465964 |
| 62 | cardiac muscle cell action potential (GO:0086001) | 4.23605452 |
| 63 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.22935142 |
| 64 | relaxation of cardiac muscle (GO:0055119) | 4.22436934 |
| 65 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.20750787 |
| 66 | plasma membrane repair (GO:0001778) | 4.20338733 |
| 67 | positive regulation of ATPase activity (GO:0032781) | 4.17984312 |
| 68 | positive regulation of ATP catabolic process (GO:1903291) | 4.17984312 |
| 69 | regulation of cardioblast proliferation (GO:0003264) | 4.16313281 |
| 70 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.16313281 |
| 71 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.15273295 |
| 72 | regulation of cell communication by electrical coupling (GO:0010649) | 4.14581351 |
| 73 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.12320514 |
| 74 | regulation of heart rate (GO:0002027) | 4.07588299 |
| 75 | regulation of skeletal muscle contraction (GO:0014819) | 4.04201124 |
| 76 | regulation of glucocorticoid metabolic process (GO:0031943) | 4.03116700 |
| 77 | endocardial cushion development (GO:0003197) | 4.02132848 |
| 78 | cardiac muscle tissue development (GO:0048738) | 4.00699268 |
| 79 | negative regulation of hormone metabolic process (GO:0032351) | 3.96412632 |
| 80 | trabecula formation (GO:0060343) | 3.95012817 |
| 81 | cell migration involved in heart development (GO:0060973) | 3.89947858 |
| 82 | heart morphogenesis (GO:0003007) | 3.86640367 |
| 83 | * positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.85369325 |
| 84 | cardiac muscle cell proliferation (GO:0060038) | 3.84271776 |
| 85 | regulation of ATP catabolic process (GO:1903289) | 3.81048303 |
| 86 | regulation of ATPase activity (GO:0043462) | 3.81048303 |
| 87 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.80600732 |
| 88 | * positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.74964966 |
| 89 | striated muscle cell development (GO:0055002) | 3.74226179 |
| 90 | * positive regulation of heart growth (GO:0060421) | 3.73078812 |
| 91 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.70859118 |
| 92 | cardiac conduction (GO:0061337) | 3.70264247 |
| 93 | regulation of heart contraction (GO:0008016) | 3.69958292 |
| 94 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.69810956 |
| 95 | negative regulation of heart growth (GO:0061117) | 3.69810956 |
| 96 | * positive regulation of cardiac muscle tissue development (GO:0055025) | 3.68429653 |
| 97 | fatty acid transmembrane transport (GO:1902001) | 3.64648846 |
| 98 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.64392104 |
| 99 | negative regulation of protein localization to cell surface (GO:2000009) | 3.63987897 |
| 100 | cellular component maintenance (GO:0043954) | 3.61926938 |
| 101 | * regulation of cardiac muscle tissue growth (GO:0055021) | 3.59305478 |
| 102 | negative regulation of potassium ion transport (GO:0043267) | 3.58894899 |
| 103 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 3.58340862 |
| 104 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.57158127 |
| 105 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.56071578 |
| 106 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.51719917 |
| 107 | gap junction assembly (GO:0016264) | 3.48176806 |
| 108 | regulation of coenzyme metabolic process (GO:0051196) | 3.46277079 |
| 109 | regulation of cofactor metabolic process (GO:0051193) | 3.46277079 |
| 110 | * regulation of cardiac muscle tissue development (GO:0055024) | 3.45589485 |
| 111 | positive regulation of heart contraction (GO:0045823) | 3.41465805 |
| 112 | regulation of muscle contraction (GO:0006937) | 3.40256511 |
| 113 | * outflow tract septum morphogenesis (GO:0003148) | 3.39447368 |
| 114 | ATP synthesis coupled proton transport (GO:0015986) | 3.35817833 |
| 115 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.35817833 |
| 116 | * regulation of cardiac muscle cell proliferation (GO:0060043) | 3.32439816 |
| 117 | regulation of cardiac muscle cell differentiation (GO:2000725) | 3.32251589 |
| 118 | striated muscle adaptation (GO:0014888) | 3.31264450 |
| 119 | negative regulation of striated muscle cell differentiation (GO:0051154) | 3.30443551 |
| 120 | regulation of tight junction assembly (GO:2000810) | 3.29275158 |
| 121 | coronary vasculature morphogenesis (GO:0060977) | 3.29150790 |
| 122 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.28360548 |
| 123 | response to epinephrine (GO:0071871) | 3.28332947 |
| 124 | desmosome organization (GO:0002934) | 3.27905005 |
| 125 | cartilage morphogenesis (GO:0060536) | 3.27627263 |
| 126 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.26414474 |
| 127 | * regulation of heart growth (GO:0060420) | 3.25905474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 7.31959452 |
| 2 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 4.61909082 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.42673404 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.17838110 |
| 5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.98360741 |
| 6 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.98360741 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.94947228 |
| 8 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.46553372 |
| 9 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.22927400 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.22099385 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.19970647 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.16615706 |
| 13 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.94069423 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.92765168 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.88593144 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.65121949 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.53465272 |
| 18 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.52248249 |
| 19 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 2.31900645 |
| 20 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.25613749 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.13462853 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.08889190 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.07211400 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.98337820 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90021777 |
| 26 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.85646287 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83238573 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80830147 |
| 29 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.71805313 |
| 30 | CJUN_26792858_Chip-Seq_BT549_Human | 1.70534492 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70236243 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.65279835 |
| 33 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.64830289 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61654257 |
| 35 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.60111561 |
| 36 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.60111561 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54217104 |
| 38 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54157413 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.53139925 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.49921360 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49694148 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49024901 |
| 43 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42531004 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42161364 |
| 45 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.40909879 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37918446 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32933784 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31357301 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30701503 |
| 50 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30683004 |
| 51 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29710934 |
| 52 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.28754371 |
| 53 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28540694 |
| 54 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.25483043 |
| 55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25096452 |
| 56 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.24622650 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23735849 |
| 58 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.23042801 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22208835 |
| 60 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.21822339 |
| 61 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.21720985 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21366707 |
| 63 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18571270 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16824915 |
| 65 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16007873 |
| 66 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13711781 |
| 67 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.13681336 |
| 68 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12627950 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11366552 |
| 70 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10490226 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10259276 |
| 72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09752320 |
| 73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09545011 |
| 74 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09050313 |
| 75 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08680822 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08136242 |
| 77 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06622691 |
| 78 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06412935 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06333736 |
| 80 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05736293 |
| 81 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05278290 |
| 82 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05123483 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05122979 |
| 84 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04707727 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02506374 |
| 86 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02101520 |
| 87 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01610512 |
| 88 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01284126 |
| 89 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01215916 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01137214 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01137214 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00947989 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99137534 |
| 94 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.98934884 |
| 95 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98880509 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97903306 |
| 97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97178272 |
| 98 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96630354 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95468493 |
| 100 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95424253 |
| 101 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95424144 |
| 102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93864632 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93265243 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92777316 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92729014 |
| 106 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92546053 |
| 107 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.89448903 |
| 108 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86590125 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86506991 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85756758 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85756758 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84057212 |
| 113 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82941879 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.81808475 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81345876 |
| 116 | TBL1_22424771_ChIP-Seq_293T_Human | 0.80749085 |
| 117 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.80346985 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79965831 |
| 119 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.79923522 |
| 120 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79865140 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79658214 |
| 122 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.78793580 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78497609 |
| 124 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.78274319 |
| 125 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.77314524 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75828691 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75806867 |
| 128 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.75752889 |
| 129 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75619442 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.75205944 |
| 131 | NFYA_21822215_ChIP-Seq_K562_Human | 0.74966802 |
| 132 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.74807925 |
| 133 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74452744 |
| 134 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.71711598 |
| 135 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.71360542 |
| 136 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.69179869 |
| 137 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.69133926 |
| 138 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.68740740 |
| 139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68685670 |
| 140 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.68682568 |
| 141 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.67835192 |
| 142 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.67808666 |
| 143 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.66781987 |
| 144 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.66767392 |
| 145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.66429556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.62303671 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.92616861 |
| 3 | MP0004215_abnormal_myocardial_fiber | 4.73266620 |
| 4 | MP0004036_abnormal_muscle_relaxation | 4.26493777 |
| 5 | MP0000751_myopathy | 3.96821537 |
| 6 | * MP0005330_cardiomyopathy | 3.89260361 |
| 7 | MP0008775_abnormal_heart_ventricle | 3.52577583 |
| 8 | * MP0002972_abnormal_cardiac_muscle | 3.46133678 |
| 9 | MP0003137_abnormal_impulse_conducting | 3.30960017 |
| 10 | MP0000749_muscle_degeneration | 3.29934702 |
| 11 | MP0003646_muscle_fatigue | 3.10702588 |
| 12 | MP0003828_pulmonary_edema | 3.07371039 |
| 13 | MP0002102_abnormal_ear_morphology | 3.00087064 |
| 14 | MP0010630_abnormal_cardiac_muscle | 2.91042401 |
| 15 | MP0006138_congestive_heart_failure | 2.88971968 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.77381734 |
| 17 | * MP0005385_cardiovascular_system_phenoty | 2.74764500 |
| 18 | * MP0001544_abnormal_cardiovascular_syste | 2.74764500 |
| 19 | * MP0005620_abnormal_muscle_contractility | 2.69462449 |
| 20 | MP0004085_abnormal_heartbeat | 2.58410930 |
| 21 | MP0002127_abnormal_cardiovascular_syste | 2.56285728 |
| 22 | MP0004484_altered_response_of | 2.36896448 |
| 23 | MP0004510_myositis | 2.32780992 |
| 24 | MP0000750_abnormal_muscle_regeneration | 2.22529102 |
| 25 | MP0003221_abnormal_cardiomyocyte_apopto | 2.22314452 |
| 26 | MP0005503_abnormal_tendon_morphology | 2.14238977 |
| 27 | * MP0002106_abnormal_muscle_physiology | 2.06125970 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.99176536 |
| 29 | * MP0003567_abnormal_fetal_cardiomyocyte | 1.93602824 |
| 30 | MP0004272_abnormal_basement_membrane | 1.90010226 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.84986284 |
| 32 | MP0002269_muscular_atrophy | 1.81566160 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.79860446 |
| 34 | * MP0005369_muscle_phenotype | 1.77408534 |
| 35 | MP0003279_aneurysm | 1.75078524 |
| 36 | MP0005451_abnormal_body_composition | 1.74680290 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.70408996 |
| 38 | MP0003122_maternal_imprinting | 1.68595844 |
| 39 | MP0004130_abnormal_muscle_cell | 1.60481608 |
| 40 | MP0009384_cardiac_valve_regurgitation | 1.58855996 |
| 41 | MP0004233_abnormal_muscle_weight | 1.47085722 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.45605035 |
| 43 | MP0005623_abnormal_meninges_morphology | 1.43166813 |
| 44 | * MP0000266_abnormal_heart_morphology | 1.39302428 |
| 45 | MP0000747_muscle_weakness | 1.38386726 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.34852642 |
| 47 | MP0000462_abnormal_digestive_system | 1.27736215 |
| 48 | MP0005248_abnormal_Harderian_gland | 1.22302696 |
| 49 | MP0005275_abnormal_skin_tensile | 1.17117972 |
| 50 | MP0003941_abnormal_skin_development | 1.12971835 |
| 51 | MP0008004_abnormal_stomach_pH | 1.10603903 |
| 52 | MP0002108_abnormal_muscle_morphology | 1.08288927 |
| 53 | MP0003123_paternal_imprinting | 1.04952587 |
| 54 | MP0002234_abnormal_pharynx_morphology | 1.03113390 |
| 55 | MP0001661_extended_life_span | 1.02189359 |
| 56 | MP0000767_abnormal_smooth_muscle | 1.00570062 |
| 57 | * MP0002128_abnormal_blood_circulation | 0.99316270 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 0.98620452 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 0.95609691 |
| 60 | MP0003121_genomic_imprinting | 0.93427007 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 0.91744402 |
| 62 | * MP0002088_abnormal_embryonic_growth/wei | 0.91325944 |
| 63 | * MP0003984_embryonic_growth_retardation | 0.90349400 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.88046340 |
| 65 | MP0005165_increased_susceptibility_to | 0.87626989 |
| 66 | MP0005377_hearing/vestibular/ear_phenot | 0.85763054 |
| 67 | MP0003878_abnormal_ear_physiology | 0.85763054 |
| 68 | * MP0002925_abnormal_cardiovascular_devel | 0.85414490 |
| 69 | MP0002697_abnormal_eye_size | 0.84102246 |
| 70 | MP0000534_abnormal_ureter_morphology | 0.83475457 |
| 71 | MP0002332_abnormal_exercise_endurance | 0.83130367 |
| 72 | MP0000343_altered_response_to | 0.79433106 |
| 73 | MP0000230_abnormal_systemic_arterial | 0.72710188 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 0.72645523 |
| 75 | * MP0001784_abnormal_fluid_regulation | 0.67337353 |
| 76 | * MP0001672_abnormal_embryogenesis/_devel | 0.65903013 |
| 77 | * MP0005380_embryogenesis_phenotype | 0.65903013 |
| 78 | MP0005187_abnormal_penis_morphology | 0.65346506 |
| 79 | MP0003890_abnormal_embryonic-extraembry | 0.65062357 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.64101929 |
| 81 | MP0000733_abnormal_muscle_development | 0.61993661 |
| 82 | * MP0001614_abnormal_blood_vessel | 0.61371683 |
| 83 | MP0009697_abnormal_copulation | 0.59944507 |
| 84 | MP0003935_abnormal_craniofacial_develop | 0.52833351 |
| 85 | MP0003115_abnormal_respiratory_system | 0.51220957 |
| 86 | MP0005388_respiratory_system_phenotype | 0.51186922 |
| 87 | MP0002133_abnormal_respiratory_system | 0.51186922 |
| 88 | MP0001958_emphysema | 0.50370863 |
| 89 | MP0003119_abnormal_digestive_system | 0.49889588 |
| 90 | MP0005197_abnormal_uvea_morphology | 0.48942447 |
| 91 | MP0005670_abnormal_white_adipose | 0.48824365 |
| 92 | MP0002233_abnormal_nose_morphology | 0.48819082 |
| 93 | MP0005595_abnormal_vascular_smooth | 0.48174358 |
| 94 | MP0000762_abnormal_tongue_morphology | 0.47983605 |
| 95 | MP0000428_abnormal_craniofacial_morphol | 0.46512828 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.46343609 |
| 97 | MP0002084_abnormal_developmental_patter | 0.45304799 |
| 98 | MP0003942_abnormal_urinary_system | 0.43760450 |
| 99 | MP0005508_abnormal_skeleton_morphology | 0.43505238 |
| 100 | MP0001697_abnormal_embryo_size | 0.43329029 |
| 101 | MP0001175_abnormal_lung_morphology | 0.43220157 |
| 102 | * MP0002086_abnormal_extraembryonic_tissu | 0.43151438 |
| 103 | MP0002009_preneoplasia | 0.40888198 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 0.40437317 |
| 105 | MP0002109_abnormal_limb_morphology | 0.40362243 |
| 106 | MP0002085_abnormal_embryonic_tissue | 0.38502250 |
| 107 | MP0002933_joint_inflammation | 0.37277502 |
| 108 | * MP0001730_embryonic_growth_arrest | 0.37198412 |
| 109 | MP0004197_abnormal_fetal_growth/weight/ | 0.36603309 |
| 110 | MP0005266_abnormal_metabolism | 0.36190910 |
| 111 | MP0005171_absent_coat_pigmentation | 0.36121593 |
| 112 | MP0002115_abnormal_skeleton_extremities | 0.34956484 |
| 113 | MP0009250_abnormal_appendicular_skeleto | 0.34427670 |
| 114 | MP0003948_abnormal_gas_homeostasis | 0.34354643 |
| 115 | MP0009672_abnormal_birth_weight | 0.34025800 |
| 116 | MP0003937_abnormal_limbs/digits/tail_de | 0.33799311 |
| 117 | MP0000516_abnormal_urinary_system | 0.33777094 |
| 118 | MP0005367_renal/urinary_system_phenotyp | 0.33777094 |
| 119 | MP0010030_abnormal_orbit_morphology | 0.29189169 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.28184325 |
| 121 | MP0005375_adipose_tissue_phenotype | 0.27335014 |
| 122 | * MP0003385_abnormal_body_wall | 0.23856412 |
| 123 | MP0000537_abnormal_urethra_morphology | 0.23820773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 9.31154136 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.23595173 |
| 3 | Atrial fibrillation (HP:0005110) | 6.90008182 |
| 4 | Primary atrial arrhythmia (HP:0001692) | 6.42149399 |
| 5 | Abnormality of the left ventricular outflow tract (HP:0011103) | 6.25832009 |
| 6 | Subaortic stenosis (HP:0001682) | 6.25832009 |
| 7 | Supraventricular tachycardia (HP:0004755) | 6.19634745 |
| 8 | Supraventricular arrhythmia (HP:0005115) | 6.10352584 |
| 9 | Lipoatrophy (HP:0100578) | 5.95578932 |
| 10 | Syncope (HP:0001279) | 5.93722632 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 5.87077907 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 5.17280032 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 5.14132082 |
| 14 | Prolonged QT interval (HP:0001657) | 5.06302831 |
| 15 | Ventricular arrhythmia (HP:0004308) | 4.99921392 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 4.98343924 |
| 17 | Muscle fiber splitting (HP:0003555) | 4.96581296 |
| 18 | Dilated cardiomyopathy (HP:0001644) | 4.66777677 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.51448287 |
| 20 | Ventricular fibrillation (HP:0001663) | 4.35069955 |
| 21 | Palpitations (HP:0001962) | 4.23975862 |
| 22 | Atrioventricular block (HP:0001678) | 4.09813377 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 4.03670356 |
| 24 | Exercise-induced myalgia (HP:0003738) | 3.97686886 |
| 25 | Hypoplastic left heart (HP:0004383) | 3.96922881 |
| 26 | Bundle branch block (HP:0011710) | 3.94740252 |
| 27 | Heart block (HP:0012722) | 3.80905917 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.77290849 |
| 29 | EMG: myopathic abnormalities (HP:0003458) | 3.75527034 |
| 30 | Abnormal EKG (HP:0003115) | 3.74695624 |
| 31 | Abnormal atrioventricular conduction (HP:0005150) | 3.66358889 |
| 32 | Double outlet right ventricle (HP:0001719) | 3.39489033 |
| 33 | Congenital malformation of the right heart (HP:0011723) | 3.39489033 |
| 34 | Myoglobinuria (HP:0002913) | 3.38948337 |
| 35 | Partial duplication of thumb phalanx (HP:0009944) | 3.07022909 |
| 36 | Left ventricular hypertrophy (HP:0001712) | 3.06470741 |
| 37 | Hypoplastic heart (HP:0001961) | 3.03864216 |
| 38 | Vitreoretinal degeneration (HP:0000655) | 3.01445441 |
| 39 | Abnormality of the ischium (HP:0003174) | 2.91939250 |
| 40 | Palmoplantar keratoderma (HP:0000982) | 2.87763526 |
| 41 | Ragged-red muscle fibers (HP:0003200) | 2.86546597 |
| 42 | Partial duplication of the phalanx of hand (HP:0009999) | 2.73662024 |
| 43 | Pulmonary artery stenosis (HP:0004415) | 2.73607069 |
| 44 | Rhabdomyolysis (HP:0003201) | 2.71904090 |
| 45 | Limited hip movement (HP:0008800) | 2.71017680 |
| 46 | Increased connective tissue (HP:0009025) | 2.69232137 |
| 47 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.55803709 |
| 48 | Periauricular skin pits (HP:0100277) | 2.51236762 |
| 49 | Preauricular pit (HP:0004467) | 2.51236762 |
| 50 | Type 1 muscle fiber predominance (HP:0003803) | 2.50153469 |
| 51 | Sudden cardiac death (HP:0001645) | 2.49583689 |
| 52 | Metaphyseal cupping (HP:0003021) | 2.48816826 |
| 53 | Abnormality of the tricuspid valve (HP:0001702) | 2.43189976 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.37736046 |
| 55 | Bicuspid aortic valve (HP:0001647) | 2.29543604 |
| 56 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.28012136 |
| 57 | Transposition of the great arteries (HP:0001669) | 2.28012136 |
| 58 | Abnormal connection of the cardiac segments (HP:0011545) | 2.28012136 |
| 59 | Myotonia (HP:0002486) | 2.27980024 |
| 60 | Neck muscle weakness (HP:0000467) | 2.26288932 |
| 61 | Congestive heart failure (HP:0001635) | 2.22317533 |
| 62 | Hepatic necrosis (HP:0002605) | 2.18268299 |
| 63 | Abnormal tarsal ossification (HP:0008369) | 2.15376105 |
| 64 | Arterial tortuosity (HP:0005116) | 2.15100088 |
| 65 | Abnormal pancreas size (HP:0012094) | 2.14543833 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.14018516 |
| 67 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.13071785 |
| 68 | Neoplasm of the adrenal gland (HP:0100631) | 2.11867646 |
| 69 | Acute necrotizing encephalopathy (HP:0006965) | 2.10089357 |
| 70 | Broad metatarsal (HP:0001783) | 2.09183252 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.08245686 |
| 72 | Abnormality of the foot musculature (HP:0001436) | 2.07300600 |
| 73 | Distal lower limb muscle weakness (HP:0009053) | 2.06261304 |
| 74 | Delayed epiphyseal ossification (HP:0002663) | 2.03228204 |
| 75 | Truncus arteriosus (HP:0001660) | 2.01762089 |
| 76 | Generalized muscle weakness (HP:0003324) | 2.01675376 |
| 77 | Neonatal hypoglycemia (HP:0001998) | 2.00144760 |
| 78 | Vascular tortuosity (HP:0004948) | 1.99793585 |
| 79 | Midline defect of the nose (HP:0004122) | 1.99622060 |
| 80 | Skin pits (HP:0100276) | 1.97717851 |
| 81 | Difficulty climbing stairs (HP:0003551) | 1.88934193 |
| 82 | Abnormality of the pubic bones (HP:0003172) | 1.88437747 |
| 83 | Preaxial foot polydactyly (HP:0001841) | 1.86147046 |
| 84 | Conjunctival hamartoma (HP:0100780) | 1.85432577 |
| 85 | Abnormality of the aortic arch (HP:0012303) | 1.84426754 |
| 86 | Rimmed vacuoles (HP:0003805) | 1.84084944 |
| 87 | Hyperglycemia (HP:0003074) | 1.83360675 |
| 88 | Mitral valve prolapse (HP:0001634) | 1.79357979 |
| 89 | Protrusio acetabuli (HP:0003179) | 1.78900579 |
| 90 | EMG: neuropathic changes (HP:0003445) | 1.77590257 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 1.77460440 |
| 92 | Diaphragmatic weakness (HP:0009113) | 1.76340637 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75960004 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 1.75960004 |
| 95 | Scapular winging (HP:0003691) | 1.75280712 |
| 96 | Underdeveloped supraorbital ridges (HP:0009891) | 1.74766906 |
| 97 | Muscular dystrophy (HP:0003560) | 1.74229302 |
| 98 | Abnormality of the fingertips (HP:0001211) | 1.74044625 |
| 99 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.73494956 |
| 100 | Aplasia of the phalanges of the hand (HP:0009802) | 1.73494956 |
| 101 | Aplasia involving bones of the extremities (HP:0009825) | 1.73494956 |
| 102 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73176715 |
| 103 | Abnormality of alanine metabolism (HP:0010916) | 1.73176715 |
| 104 | Hyperalaninemia (HP:0003348) | 1.73176715 |
| 105 | Visceral angiomatosis (HP:0100761) | 1.72349212 |
| 106 | Premature rupture of membranes (HP:0001788) | 1.71745665 |
| 107 | Increased CSF lactate (HP:0002490) | 1.71720904 |
| 108 | Exercise intolerance (HP:0003546) | 1.71689578 |
| 109 | Hepatocellular necrosis (HP:0001404) | 1.70184606 |
| 110 | Pheochromocytoma (HP:0002666) | 1.69488954 |
| 111 | Progressive macrocephaly (HP:0004481) | 1.68501883 |
| 112 | Duplication of thumb phalanx (HP:0009942) | 1.67927085 |
| 113 | Acute encephalopathy (HP:0006846) | 1.66938033 |
| 114 | Mitochondrial inheritance (HP:0001427) | 1.65783521 |
| 115 | Areflexia of lower limbs (HP:0002522) | 1.65145869 |
| 116 | Ketoacidosis (HP:0001993) | 1.64110002 |
| 117 | Hip contracture (HP:0003273) | 1.63977331 |
| 118 | Neonatal death (HP:0003811) | 1.62673080 |
| 119 | Hemangiomatosis (HP:0007461) | 1.62211160 |
| 120 | Cerebral edema (HP:0002181) | 1.62057386 |
| 121 | Skull defect (HP:0001362) | 1.61987017 |
| 122 | Foot dorsiflexor weakness (HP:0009027) | 1.61934536 |
| 123 | Aneurysm (HP:0002617) | 1.61555548 |
| 124 | Hypoplastic ischia (HP:0003175) | 1.61246653 |
| 125 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.60781284 |
| 126 | Bradycardia (HP:0001662) | 1.60558196 |
| 127 | Ankle contracture (HP:0006466) | 1.59244160 |
| 128 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.59221583 |
| 129 | Bell-shaped thorax (HP:0001591) | 1.59079610 |
| 130 | Lymphangioma (HP:0100764) | 1.58768678 |
| 131 | * Patent foramen ovale (HP:0001655) | 1.57606851 |
| 132 | Choanal stenosis (HP:0000452) | 1.57292946 |
| 133 | Abnormality of glycolysis (HP:0004366) | 1.54968492 |
| 134 | Mixed hearing impairment (HP:0000410) | 1.54193548 |
| 135 | Aortic dissection (HP:0002647) | 1.53358505 |
| 136 | Steppage gait (HP:0003376) | 1.52874575 |
| 137 | Aplasia of the musculature (HP:0100854) | 1.48552165 |
| 138 | Abnormal foot bone ossification (HP:0010675) | 1.47628777 |
| 139 | Maternal diabetes (HP:0009800) | 1.44046621 |
| 140 | Abnormality of the lacrimal duct (HP:0011481) | 1.43828692 |
| 141 | Neonatal short-limb short stature (HP:0008921) | 1.42547005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.23554952 |
| 2 | STK24 | 5.41649864 |
| 3 | MYLK | 4.54774366 |
| 4 | PKN2 | 3.47831074 |
| 5 | DMPK | 3.16831200 |
| 6 | ZAK | 3.12126701 |
| 7 | TTN | 2.87926311 |
| 8 | STK38L | 2.86198515 |
| 9 | LMTK2 | 2.72596914 |
| 10 | TIE1 | 2.67750691 |
| 11 | PDK3 | 2.65858897 |
| 12 | PDK4 | 2.65858897 |
| 13 | PIK3CA | 2.53637739 |
| 14 | NEK1 | 2.37457791 |
| 15 | PHKG2 | 2.14554634 |
| 16 | PHKG1 | 2.14554634 |
| 17 | ILK | 1.97742999 |
| 18 | CDC42BPA | 1.63968779 |
| 19 | PDK2 | 1.57143738 |
| 20 | WNK4 | 1.49646534 |
| 21 | INSRR | 1.49329054 |
| 22 | TRIB3 | 1.44520322 |
| 23 | TRPM7 | 1.43138368 |
| 24 | FLT3 | 1.37576598 |
| 25 | GRK7 | 1.28678942 |
| 26 | PAK3 | 1.24402324 |
| 27 | MAP3K10 | 1.20768931 |
| 28 | CAMK2D | 1.18176928 |
| 29 | ROCK1 | 1.18150300 |
| 30 | MAP3K5 | 1.16915104 |
| 31 | RET | 1.15821228 |
| 32 | STK4 | 1.14108756 |
| 33 | MUSK | 1.08489556 |
| 34 | STK3 | 1.08171751 |
| 35 | DAPK3 | 1.06501451 |
| 36 | WNK1 | 0.97404596 |
| 37 | LATS1 | 0.96723487 |
| 38 | PRKD1 | 0.93273403 |
| 39 | PLK4 | 0.92151876 |
| 40 | DDR2 | 0.91227157 |
| 41 | BCKDK | 0.90426937 |
| 42 | PINK1 | 0.85619599 |
| 43 | LIMK1 | 0.83718206 |
| 44 | ERBB4 | 0.82181638 |
| 45 | PDGFRA | 0.81681740 |
| 46 | KDR | 0.80172870 |
| 47 | PTK2B | 0.77443789 |
| 48 | PRKAA1 | 0.75665394 |
| 49 | MAPKAPK3 | 0.73631197 |
| 50 | PRKAA2 | 0.68817856 |
| 51 | CAMK4 | 0.68798484 |
| 52 | AKT3 | 0.67799616 |
| 53 | MAP3K7 | 0.66748992 |
| 54 | MAPK12 | 0.64062930 |
| 55 | NUAK1 | 0.63754097 |
| 56 | FGFR2 | 0.63255304 |
| 57 | CAMK1 | 0.62398290 |
| 58 | FRK | 0.62269522 |
| 59 | NEK9 | 0.62122923 |
| 60 | ICK | 0.62046408 |
| 61 | RIPK1 | 0.59726981 |
| 62 | BCR | 0.56290505 |
| 63 | TGFBR1 | 0.55953346 |
| 64 | LATS2 | 0.55366789 |
| 65 | TNIK | 0.54563912 |
| 66 | CAMK2A | 0.53690633 |
| 67 | TGFBR2 | 0.52156680 |
| 68 | PRKCE | 0.51462544 |
| 69 | PRKD3 | 0.47954847 |
| 70 | EPHB2 | 0.47224247 |
| 71 | PRKACB | 0.47190946 |
| 72 | MAP3K3 | 0.47158819 |
| 73 | STK38 | 0.46488211 |
| 74 | STK39 | 0.46181406 |
| 75 | PAK2 | 0.44530230 |
| 76 | EEF2K | 0.44292456 |
| 77 | MAP3K6 | 0.40813445 |
| 78 | CDK4 | 0.39936504 |
| 79 | ROCK2 | 0.39810419 |
| 80 | PLK2 | 0.38306712 |
| 81 | NLK | 0.38257571 |
| 82 | PRKACA | 0.37954564 |
| 83 | MAPK4 | 0.36894617 |
| 84 | PDK1 | 0.34084458 |
| 85 | RPS6KL1 | 0.33946713 |
| 86 | RPS6KC1 | 0.33946713 |
| 87 | AKT2 | 0.31866501 |
| 88 | PRKACG | 0.30486864 |
| 89 | FGFR1 | 0.29042401 |
| 90 | MAP2K3 | 0.28392578 |
| 91 | PKN1 | 0.27787971 |
| 92 | MAPK7 | 0.27566679 |
| 93 | PRKG1 | 0.27472724 |
| 94 | SGK2 | 0.25651715 |
| 95 | MELK | 0.25092677 |
| 96 | TTK | 0.24217337 |
| 97 | PTK2 | 0.23341293 |
| 98 | CAMK2G | 0.22912490 |
| 99 | MAPK10 | 0.22699919 |
| 100 | RPS6KA6 | 0.22530441 |
| 101 | MET | 0.22401575 |
| 102 | MARK3 | 0.22340839 |
| 103 | BRD4 | 0.21396337 |
| 104 | AURKB | 0.18759845 |
| 105 | RPS6KB2 | 0.18628145 |
| 106 | MTOR | 0.18535575 |
| 107 | NEK2 | 0.17460803 |
| 108 | FER | 0.17394554 |
| 109 | SCYL2 | 0.17074935 |
| 110 | SGK3 | 0.16999559 |
| 111 | MARK1 | 0.15704902 |
| 112 | AKT1 | 0.15607526 |
| 113 | ADRBK1 | 0.15065562 |
| 114 | PTK6 | 0.14934232 |
| 115 | TESK1 | 0.14872592 |
| 116 | MARK2 | 0.14792636 |
| 117 | PRKDC | 0.14666307 |
| 118 | DYRK1B | 0.13388825 |
| 119 | PRKG2 | 0.13216095 |
| 120 | RPS6KA1 | 0.13046542 |
| 121 | BRSK2 | 0.12018925 |
| 122 | ACVR1B | 0.11989221 |
| 123 | PRPF4B | 0.10399080 |
| 124 | PRKCQ | 0.10164110 |
| 125 | IGF1R | 0.07750587 |
| 126 | PDGFRB | 0.07726688 |
| 127 | UHMK1 | 0.07533275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.67181972 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 5.03667813 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 5.01364365 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.87279809 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.77289849 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.34065518 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.83463224 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.55394870 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.48745238 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38296634 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.27884366 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.27508002 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.17335186 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.01357540 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.89746245 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.89687607 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.70401490 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68797190 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60582235 |
| 20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.39152755 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.35549485 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34577049 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34444227 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27800797 |
| 25 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.21703097 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.19957563 |
| 27 | Adherens junction_Homo sapiens_hsa04520 | 1.15719903 |
| 28 | Tight junction_Homo sapiens_hsa04530 | 1.11823406 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10517049 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10228761 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08808158 |
| 32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.08467242 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.06127994 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05392532 |
| 35 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.02192302 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85379844 |
| 37 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84169852 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81128152 |
| 39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75639645 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75305678 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74792478 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 0.74651568 |
| 43 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73358707 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 0.73275442 |
| 45 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65932838 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 0.65116800 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64912776 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63171221 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63017385 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62913381 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62028274 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.61616710 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61164346 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60932639 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57637114 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57268841 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57123282 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56388281 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54695908 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53919409 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53397275 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53319938 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50840143 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50785938 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50093237 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49777096 |
| 67 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49534327 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49137133 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.48441550 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46961133 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.46941010 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46125676 |
| 73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45247198 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43797211 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.43517235 |
| 76 | Melanoma_Homo sapiens_hsa05218 | 0.41257445 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38529400 |
| 78 | Axon guidance_Homo sapiens_hsa04360 | 0.37243130 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.35564117 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35258121 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32177263 |
| 82 | Malaria_Homo sapiens_hsa05144 | 0.31736160 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.31057315 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29599432 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.28654110 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.28473712 |
| 87 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28162104 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26655440 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.25815327 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25772369 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25164647 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25154926 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24541545 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24459435 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24355920 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.23669020 |
| 97 | Circadian entrainment_Homo sapiens_hsa04713 | 0.22679434 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22200108 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21167393 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20154302 |
| 101 | Insulin secretion_Homo sapiens_hsa04911 | 0.19754735 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19728366 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.19673319 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.19411365 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.19300186 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19223730 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.18138030 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15461374 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.15180413 |
| 110 | Proteasome_Homo sapiens_hsa03050 | 0.14804652 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.13849253 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11598538 |
| 113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.09747325 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.09258732 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.08772551 |
| 116 | Peroxisome_Homo sapiens_hsa04146 | 0.08372097 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.08348253 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.08288540 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.08031915 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07498419 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.07051243 |
| 122 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.06766454 |
| 123 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.06620662 |
| 124 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.04321225 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.04229759 |
| 126 | Purine metabolism_Homo sapiens_hsa00230 | 0.01355388 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.01159534 |

